Announcement: Bao Jun was appointed as the President & CEO of IMPACT Therapeutics, Inc.
The appointment was effective on Oct.01, 2018. The appointment will help the development of IMPACT Therapeutics, Inc. in China as well as globally. This is a strategic step taken by the Company.
Bao Jun, Senior BD, with more than 20 years of comprehensive experience in the production and research, extensive experience in drug research and development, technology transfer, licensing and business development, venture investment, entrepreneurship and corporate finance. Most recently, he was SVP & CBO at Shenogen Pharma. He also worked as Director of corporate development and financial planning in Onyx followed by Director of Worldwide BD & Head of China BD in GSK.
Dr. Bao Jun says: “Impact is an emerging leader in DDR field. The company pipeline holds great promise with a capable team. I am really glad to have the opportunity to lead the company to bring novel treatment to the patients”